Long-acting β-agonists in asthma management: What is the current status? Drugs. 2011; 71 :2091–7.Mysore S, Ruffin RE. Long-acting b-agonists in asthma mana- gement: what is the current status? Drugs. 2011;71:2091-7.Mysore S, Ruffin RE. Long-acting b-agonists in asthma management:...
There are data to suggest that asthma in older adults is phenotypically different from young patients, with potential impact on the diagnosis, assessment and management in this population. The diagnosis of AIE in older populations relies on the same clinical findings and diagnostic tests used in ...
of triple therapy in multiple clinical trials. However, there was no specific guidance on how to handle patients who are on LABA+ICS, and this gap is covered by the 2025 document, that provides recommendations based on prior exacerbation history and/or beneficial response with LABA+ICS: ...
It is clear that Montelukast has at best a role in a minority of asthmatics at any age. This was confirmed in an adult study of really severe asthma [25]; 100 adult asthmatics were recruited. They were prescribed ICS 250-4000mcg (Fluticasone equivalent) and the data were analysable in...
Inhalation therapy is largely used in pulmonary critical care. It represents the mainstay of treating respiratory diseases e.g. asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Inhaled bronchodilators and inhaled corticosteroids
In this study, 37% of patients had a concomitant diagnosis of asthma. ICS is a key component of asthma treatment, and although a large proportion of our overall cohort may have been considered appropriate in this study to step down from the GOLD groups C and D, they may be more appropria...
It uses a number of data mining, predictive modeling and analytical techniques to bring together the management, information technology, and modeling business process to make predictions about future. The patterns found in historical and transactional data can be used to identify risks and opportunities...
Should biologics for severe asthma be used differently in the COVID-19 era? Management of patients with severe asthma during the COVID-19 pandemic may be a challenge, particularly of those on therapy with biologics. In the event they get infected with SARS-CoV-2 and develop COVID-19, the...
In the past, asthma was considered mainly as a childhood disease. However, asthma is an important cause of morbidity and mortality in the elderly nowadays. In addition, the burden of asthma is more significant in the elderly than in their younger counter
According to current knowledge, COPD is mainly a Th1-mediated inflammatory condition characterized by neutrophil prepon- derance and an increase in alveolar macrophages and CD8+ T cells, while asthma, which is a dif- ferent chronic airway inflammatory disease, is often characterized by eosinophilic...